|1.||Irie, K: 2 articles (03/2001 - 09/2000)|
|2.||Ohigashi, H: 2 articles (03/2001 - 09/2000)|
|3.||Nakagawa, Y: 2 articles (03/2001 - 09/2000)|
|4.||Ozanne, Daniel M: 1 article (11/2003)|
|5.||Rigas, Anastasia C: 1 article (11/2003)|
|6.||Neal, David E: 1 article (11/2003)|
|7.||Robson, Craig N: 1 article (11/2003)|
|8.||Nakamura, Y: 1 article (03/2001)|
|9.||Wender, P A: 1 article (09/2000)|
|10.||Hayashi, H: 1 article (09/2000)|
06/01/1987 - "(-)-Indolactam-V, which has the partial structure of teleocidins A and B, and has tumor-promoting activity, is a good model for use in studies on the relation between structure and tumor-promoting activity, whereas (+)-indolactam-V has no tumor-promoting activity. "
09/18/2000 - "Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V."
08/01/1997 - "The tumor promoter (-)-indolactam-V (1) exists in two stable conformers (twist and sofa) due to isomerization of the amide group. "
06/01/1987 - "In this work, five racemic indolactams differing only in their alkyl group at C-12 of (-)-indolactam-V were synthesized and tested for biological and biochemical activities related to tumor promotion. "
08/01/1998 - "Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V."
|2.||Prostatic Neoplasms (Prostate Cancer)
08/15/1989 - "The effects of a synthetic protein kinase C (PKC) activator, (-)-indolactam V (ILV), were studied in SH-SY5Y human neuroblastoma cells. "
08/15/1989 - "(-)-Indolactam V activates protein kinase C and induces changes in muscarinic receptor functions in SH-SY5Y human neuroblastoma cells."
|2.||Protein Kinase C
|5.||Arachidonic Acid (Vitamin F)
|7.||Messenger RNA (mRNA)
|8.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)